These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2486568)
1. Targeting of monoclonal antibodies to tumours. Courtenay-Luck NS; Epenetos AA Curr Opin Immunol; 1989-1990; 2(6):880-3. PubMed ID: 2486568 [No Abstract] [Full Text] [Related]
2. [Monoclonal antibodies and cancer]. López González JS; Selman Lama M Salud Publica Mex; 1985; 27(3):213-34. PubMed ID: 2996157 [No Abstract] [Full Text] [Related]
3. Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodies. Vollmers HP; Brändlein S Hum Antibodies; 2002; 11(4):131-42. PubMed ID: 12775893 [TBL] [Abstract][Full Text] [Related]
4. Potential clinical utility of monoclonal antibodies in the management of human carcinomas. Schlom J; Weeks MO Important Adv Oncol; 1985; ():170-92. PubMed ID: 3916739 [No Abstract] [Full Text] [Related]
12. In vivo diagnosis and therapy of human tumors with monoclonal antibodies. Part I. Proceedings of a symposium. Naples, Italy, 16-19 March 1988. Int J Rad Appl Instrum B; 1989; 16(2):103-185. PubMed ID: 2715003 [No Abstract] [Full Text] [Related]
16. State of the art in anti-cancer mAbs. Chiavenna SM; Jaworski JP; Vendrell A J Biomed Sci; 2017 Feb; 24(1):15. PubMed ID: 28219375 [TBL] [Abstract][Full Text] [Related]
17. Biologicals for cancer treatment: monoclonal antibodies. Levy R Hosp Pract (Off Ed); 1985 Nov; 20(11):67-74, 77, 80-4 passim. PubMed ID: 3932392 [No Abstract] [Full Text] [Related]
18. Radioantibodies for the diagnosis and treatment of cancer; radioimmunoimaging (RAI) and radioimmunotherapy (RAT). Sfakianakis GN; Garty II; Serafini AN Cancer Invest; 1990; 8(3-4):381-405. PubMed ID: 2207765 [No Abstract] [Full Text] [Related]
19. Overview of monoclonal antibodies in cancer therapy: present and promise. Stern M; Herrmann R Crit Rev Oncol Hematol; 2005 Apr; 54(1):11-29. PubMed ID: 15780905 [TBL] [Abstract][Full Text] [Related]
20. Intervention in receptor tyrosine kinase-mediated pathways: recombinant antibody fusion proteins targeted to ErbB2. Wels W; Groner B; Hynes NE Curr Top Microbiol Immunol; 1996; 213 ( Pt 3)():113-28. PubMed ID: 8815001 [No Abstract] [Full Text] [Related] [Next] [New Search]